HEPION PHARMACEUTICALS INC (HEPA) Stock Analyst Ratings
USA - NASDAQ:HEPA - US4268974015 - Common Stock
0.318 USD
-0.07 (-18.79%)
0.1748 USD
-0.14 (-45.03%)
ChartMill assigns a Buy % Consensus number of 83% to HEPA. The Buy consensus is the weighted average rating of the current analysts ratings.
HEPA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HEPA.
In the previous month the buy percentage consensus was at a similar level.
HEPA was analyzed by 7 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-07 | Brookline Capital | Downgrade | Buy -> Hold |
| 2022-02-28 | Cantor Fitzgerald | Initiate | Overweight |
HEPION PHARMACEUTICALS INC / HEPA FAQ
Can you provide the consensus rating for HEPION PHARMACEUTICALS INC stock?
The consensus rating for HEPION PHARMACEUTICALS INC (HEPA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for HEPION PHARMACEUTICALS INC stock?
The number of analysts covering HEPION PHARMACEUTICALS INC (HEPA) is 7.